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HIV envelope glycoprotein (Env) mediates infection by
fusing virus with cellular membranes. Fusion inhibitors, a
new class of antiretroviral drugs, inhibit HIV infection by
binding to gp41 to form a peptide-gp41 6HB that is
fusion-incompetent. To understand resistance mecha-
nisms to peptide fusion inhibitors that will aid develop-
ment of new drugs, we generated an escape-mutant virus
against an N-peptide inhibitor. We found that two muta-
tions in gp41, one each in the N- and C- heptad repeats,
confer early resistance to the N peptide. These same muta-
tions also confer resistance to a C peptide inhibitor. This
is the first report of cross-resistance among peptide fusion
inhibitors. Curiously, the N mutation alone or in combi-
nation with C mutation also conferred increased sensitiv-
ity to soluble CD4 and was associated with faster growth
kinetics and larger syncytia. These results suggest global
changes in Env involving receptor activation and fusion
kinetics. Using thermal denaturation studies, involving N
and C peptides containing wild type (Nw or Cw) or resist-
ance residues (Nm or Cm), which self-assemble into a
6HB, we showed that the N mutation improved the ener-
getics of the viral 6HB, however, the energetics of the 6HB
formed with the inhibitor and the N and C peptides is not
afffected. Thus, our results demonstrate a resistance path-
way that appears to involve both kinetic and thermody-
namic factors that regulate virus entry and work indirectly
to reduce the ability of fusion inhibitors to bind Env.
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